Literature DB >> 28356995

Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis.

Rui Liu1, Ping Ji2, Bin Liu1, Haishi Qiao2, Xia Wang1, Likun Zhou1, Ting Deng1, Yi Ba1.   

Abstract

Epidemiological and experimental evidence suggests that dietary flavonoids, including apigenin, have anticancer roles. Apigenin has been reported to elevate p53, a critical molecule in the induction of apoptosis. The present study aimed to investigate whether apigenin, a dietary flavonoid, improves the cytotoxic effect of cisplatin in a cancer cell culture system, and to elucidate the mechanism of this effect. Multiple tumor cell types were treated with apigenin, cisplatin or both drugs. Cell viability was evaluated, and the cytotoxic effect was determined biochemically and microscopically. Treatment with apigenin increased cisplatin-induced DNA damage and the apoptosis of tumor cells in a p53-dependent manner. Apigenin, when used with cisplatin, inhibited cell proliferation and promoted mitogen-activated protein kinase activation and subsequent p53 phosphorylation, leading to p53 accumulation and upregulation of proapoptotic proteins. Cisplatin is one of the most commonly used chemotherapeutic drugs for malignant tumors, but resistance to this drug occurs. The current results therefore demonstrate that dietary flavonoids may diminish the resistance of cancers to cisplatin.

Entities:  

Keywords:  apigenin; apoptosis; cancer; cisplatin; p53

Year:  2016        PMID: 28356995      PMCID: PMC5351382          DOI: 10.3892/ol.2016.5495

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  48 in total

1.  Sulfated polysaccharide isolated from the sea cucumber Stichopus japonicas promotes the SDF-1α/CXCR4 axis-induced NSC migration via the PI3K/Akt/FOXO3a, ERK/MAPK, and NF-κB signaling pathways.

Authors:  Chao Cui; Peng Wang; Ningshan Cui; Shuliang Song; Hao Liang; Aiguo Ji
Journal:  Neurosci Lett       Date:  2016-01-28       Impact factor: 3.046

2.  Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.

Authors:  Aantonio Angelini; C Di Ilio; M L Castellani; P Conti; F Cuccurullo
Journal:  J Biol Regul Homeost Agents       Date:  2010 Apr-Jun       Impact factor: 1.711

3.  Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models.

Authors:  Meher U Nessa; Philip Beale; Charles Chan; Jun Q Yu; Fazlul Huq
Journal:  Anticancer Res       Date:  2011-11       Impact factor: 2.480

4.  Mutant p53 disrupts the stress MAPK activation circuit induced by ASK1-dependent stabilization of Daxx.

Authors:  Tetsuya Kitamura; Yayoi Fukuyo; Masahiro Inoue; Nobuko T Horikoshi; Masanobu Shindoh; Buck E Rogers; Anny Usheva; Nobuo Horikoshi
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

5.  5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells.

Authors:  Eun J Choi; Gun-Hee Kim
Journal:  Oncol Rep       Date:  2009-12       Impact factor: 3.906

6.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

7.  Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives.

Authors:  Iris L K Wong; Kin-Fai Chan; Ka Hing Tsang; Chi Yin Lam; Yunzhe Zhao; Tak Hang Chan; Larry Ming Cheung Chow
Journal:  J Med Chem       Date:  2009-09-10       Impact factor: 7.446

8.  Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy.

Authors:  R R Ruela-de-Sousa; G M Fuhler; N Blom; C V Ferreira; H Aoyama; M P Peppelenbosch
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

9.  Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells.

Authors:  Yimiao Xu; Yinqiang Xin; Ying Diao; Changyan Lu; Jin Fu; Lan Luo; Zhimin Yin
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

10.  Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation.

Authors:  Xiaoqing Chen; Zhongxia Wang; Ziying Yang; Jingjing Wang; Yunxia Xu; Ren-Xiang Tan; Erguang Li
Journal:  Antiviral Res       Date:  2011-09-17       Impact factor: 5.970

View more
  12 in total

1.  Toll-like receptor 9 activation by CpG oligodeoxynucleotide 7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway.

Authors:  Sujuan Yuan; Tiankui Qiao; Xuan Li; Xibing Zhuang; Wei Chen; Xue Chen; Qi Zhang
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

Review 2.  Apigenin in cancer therapy: anti-cancer effects and mechanisms of action.

Authors:  Xiaohui Yan; Miao Qi; Pengfei Li; Yihong Zhan; Huanjie Shao
Journal:  Cell Biosci       Date:  2017-10-05       Impact factor: 7.133

Review 3.  Progress in Research on the Role of Flavonoids in Lung Cancer.

Authors:  Oana Zanoaga; Cornelia Braicu; Ancuta Jurj; Alexandru Rusu; Rares Buiga; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2019-09-02       Impact factor: 5.923

Review 4.  Flavonoids as Anticancer Agents.

Authors:  Dalia M Kopustinskiene; Valdas Jakstas; Arunas Savickas; Jurga Bernatoniene
Journal:  Nutrients       Date:  2020-02-12       Impact factor: 5.717

5.  CYP1B1 as a therapeutic target in cardio-oncology.

Authors:  Alexa N Carrera; Marianne K O Grant; Beshay N Zordoky
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

6.  Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling.

Authors:  Thu Ha Pham; Yann Le Page; Frédéric Percevault; François Ferrière; Gilles Flouriot; Farzad Pakdel
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

7.  Apigenin Inhibits the Histamine-Induced Proliferation of Ovarian Cancer Cells by Downregulating ERα/ERβ Expression.

Authors:  Manman Liu; Yani Zhang; Qiqi Xu; Guirong Liu; Na Sun; Huilian Che; Tao He
Journal:  Front Oncol       Date:  2021-09-08       Impact factor: 6.244

Review 8.  Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin.

Authors:  Jung Yoon Jang; Bokyung Sung; Nam Deuk Kim
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

9.  Apigenin and Hesperidin Downregulate DNA Repair Genes in MCF-7 Breast Cancer Cells and Augment Doxorubicin Toxicity.

Authors:  Agnieszka Korga-Plewko; Monika Michalczyk; Grzegorz Adamczuk; Ewelina Humeniuk; Marta Ostrowska-Lesko; Aleksandra Jozefczyk; Magdalena Iwan; Marta Wojcik; Jaroslaw Dudka
Journal:  Molecules       Date:  2020-09-26       Impact factor: 4.411

Review 10.  Influence of Olive Oil and Its Components on Breast Cancer: Molecular Mechanisms.

Authors:  Raquel Moral; Eduard Escrich
Journal:  Molecules       Date:  2022-01-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.